DE3575377D1 - 2-guanidin-4-(2-methyl-4-imidazolyl)thiazole in der behandlung von rheumatoider arthritis. - Google Patents

2-guanidin-4-(2-methyl-4-imidazolyl)thiazole in der behandlung von rheumatoider arthritis.

Info

Publication number
DE3575377D1
DE3575377D1 DE8585307058T DE3575377T DE3575377D1 DE 3575377 D1 DE3575377 D1 DE 3575377D1 DE 8585307058 T DE8585307058 T DE 8585307058T DE 3575377 T DE3575377 T DE 3575377T DE 3575377 D1 DE3575377 D1 DE 3575377D1
Authority
DE
Germany
Prior art keywords
guanidine
thiazole
imidazolyl
methyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585307058T
Other languages
English (en)
Inventor
David Lee Larson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3575377D1 publication Critical patent/DE3575377D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE8585307058T 1984-10-11 1985-10-02 2-guanidin-4-(2-methyl-4-imidazolyl)thiazole in der behandlung von rheumatoider arthritis. Expired - Fee Related DE3575377D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65975084A 1984-10-11 1984-10-11
US06/763,730 US4591595A (en) 1984-10-11 1985-08-09 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis

Publications (1)

Publication Number Publication Date
DE3575377D1 true DE3575377D1 (de) 1990-02-22

Family

ID=27097889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585307058T Expired - Fee Related DE3575377D1 (de) 1984-10-11 1985-10-02 2-guanidin-4-(2-methyl-4-imidazolyl)thiazole in der behandlung von rheumatoider arthritis.

Country Status (5)

Country Link
US (1) US4591595A (de)
EP (1) EP0178822B1 (de)
DE (1) DE3575377D1 (de)
IE (1) IE58204B1 (de)
PH (1) PH21500A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6436394A (en) * 1993-06-15 1995-01-03 Pfizer Inc. H2-antagonists as immune stimulants in bacterial infections of cattle or swine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374843A (en) * 1980-10-14 1983-02-22 Pfizer Inc. 2-Guanidino-4-heteroarylthiazoles

Also Published As

Publication number Publication date
EP0178822A2 (de) 1986-04-23
PH21500A (en) 1987-11-10
IE58204B1 (en) 1993-07-28
EP0178822A3 (en) 1988-01-13
US4591595A (en) 1986-05-27
IE852497L (en) 1986-04-11
EP0178822B1 (de) 1990-01-17

Similar Documents

Publication Publication Date Title
NO162124C (no) Forspent bjelke av trevirke.
DE3579603D1 (de) Stickstoffhaltige heterocyclen.
DE3481415D1 (de) Stickstoffhaltige heterocyclen.
FI843381A0 (fi) Foerfarande foer visualisering av plan i en vaetskestroemning med protonkaernmagnetisk resonansavbildning.
DE3869007D1 (de) Oxydation von alkanen.
FI871632A0 (fi) Heterocykliska karboxamider.
DE3585080D1 (de) Manipulation von objekten am bildschirm.
FI883581A (fi) Anordning foer beskiktning av en materialbana.
ATE112172T1 (de) Targetformer von antitumor-methyltrithioagenzien.
DE3587119D1 (de) Fluessiges zuechten von nematoden.
IT8124015A0 (it) Disposizione di trasportatori.
FI820188L (fi) Monteringsstoed foer ljusemitterande diod i en belyst tryckknappselomkopplare
FI842152A0 (fi) Matningsanordning vid skoerdare.
IT8420682A0 (it) Procedimento per il trattamento di articoli di maglieria.
DE3575377D1 (de) 2-guanidin-4-(2-methyl-4-imidazolyl)thiazole in der behandlung von rheumatoider arthritis.
DE68922653D1 (de) Herstellungsverfahren von Metall-Halbleiter Feldeffekttransistoren.
FI844914L (fi) Signaleringsterminalsystem foer signaleringssystem nr.7.
ATE49504T1 (de) 2-guanidin-4-(2-methyl-4-imidazolyl)thiazole in der behandlung von rheumatoider arthritis.
FI853858L (fi) Med klister foersedd vaeggbeklaednad.
FI852772A0 (fi) Formsten.
DE3861556D1 (de) Verhinderung von ablagerungen.
DE3675720D1 (de) Behandlung von material aus lignocellulose.
DE3480814D1 (de) Oberflaechenwellen-convolveranordnung.
ES547163A0 (es) Perfeccionamientos en los aparatos de elaboracion de cierresde cremallera
NO157828C (no) Behandling av treflis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee